Applying Evidence to Patient Care: From Black and White to Shades of Grey
DOI: 10.7326/0003-4819-138-11-200306030-00016
关键词: White (horse) 、 Observational study 、 Medicine 、 Dilemma 、 Cohort study 、 Intensive care medicine 、 Clinical trial 、 Family medicine 、 Patient care 、 Population 、 Internal medicine 、 General Medicine
摘要: This editorial focuses on the dilemma at heart of Dr. Shlipak's paper in this issue: How can we extrapolate from trials conducted highly selected patients to a broader population patients...
sci-hub.se 参考文章(16)
Peter Sleight, Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them! Trials. ,vol. 1, pp. 25- 27 ,(2000) , 10.1186/CVM-1-1-025
Michael G Shlipak, Warren S Browner, Haruko Noguchi, Barry Massie, Craig D Frances, Mark McClellan, Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction. The American Journal of Medicine. ,vol. 110, pp. 425- 433 ,(2001) , 10.1016/S0002-9343(01)00652-0
Don D Sin, Finlay A McAlister, The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure The American Journal of Medicine. ,vol. 113, pp. 650- 656 ,(2002) , 10.1016/S0002-9343(02)01346-3
Nisha C. Chandra, Observations of the Treatment of Women in the United States With Myocardial InfarctionA Report From the National Registry of Myocardial Infarction-I Archives of Internal Medicine. ,vol. 158, pp. 981- 988 ,(1998) , 10.1001/ARCHINTE.158.9.981
Asefeh Heiat, Cary P. Gross, Harlan M. Krumholz, Representation of the Elderly, Women, and Minorities in Heart Failure Clinical Trials Archives of Internal Medicine. ,vol. 162, pp. 1682- 1688 ,(2002) , 10.1001/ARCHINTE.162.15.1682
Marcus D Flather, Salim Yusuf, Lars Køber, Marc Pfeffer, Alistair Hall, Gordon Murray, Christian Torp-Pedersen, Stephen Ball, Janice Pogue, Lemuel Moyé, Eugene Braunwald, Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients The Lancet. ,vol. 355, pp. 1575- 1581 ,(2000) , 10.1016/S0140-6736(00)02212-1
Finlay A McAlister, David L Sackett, Active-control equivalence trials and antihypertensive agents The American Journal of Medicine. ,vol. 111, pp. 553- 558 ,(2001) , 10.1016/S0002-9343(01)00900-7
Andrew D Oxman, Gordon H Guyatt, A Consumer's Guide to Subgroup Analyses Annals of Internal Medicine. ,vol. 116, pp. 78- 84 ,(1992) , 10.7326/0003-4819-116-1-78
Susan F Assmann, Stuart J Pocock, Laura E Enos, Linda E Kasten, Subgroup analysis and other (mis)uses of baseline data in clinical trials. The Lancet. ,vol. 355, pp. 1064- 1069 ,(2000) , 10.1016/S0140-6736(00)02039-0
C.D. Naylor, Grey zones of clinical practice: some limits to evidence-based medicine The Lancet. ,vol. 345, pp. 840- 842 ,(1995) , 10.1016/S0140-6736(95)92969-X